BANK OF MONTREAL /CAN/ - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$551,000
+26.1%
36,720
+2.2%
0.00%
Q1 2016$437,000
-9.0%
35,946
+19.2%
0.00%
-100.0%
Q4 2015$480,000
+26.3%
30,163
+21.5%
0.00%0.0%
Q3 2015$380,000
-49.3%
24,816
-19.5%
0.00%0.0%
Q2 2015$750,000
+34.9%
30,829
+29.1%
0.00%0.0%
Q1 2015$556,000
+54.0%
23,879
+66.2%
0.00%
Q4 2014$361,000
-7.4%
14,365
+14.4%
0.00%
Q3 2014$390,000
+18.9%
12,556
-1.3%
0.00%
Q2 2014$328,000
+15.1%
12,718
+4.5%
0.00%
Q1 2014$285,000
+5.2%
12,173
+13.9%
0.00%
Q4 2013$271,000
+39.7%
10,683
+12.5%
0.00%
Q3 2013$194,0009,4970.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders